Osimertinib vs Trimethoprim
Osimertinib vs Trimethoprim: Overview
This comparison examines the pharmacological differences between Osimertinib and Trimethoprim.
Mechanism of Action
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Trimethoprim: Dihydrofolate reductase inhibitor (bacterial selective).
Pharmacokinetics
Half-life: Osimertinib β 48 hours; Trimethoprim β 8-10 hours.
Chemical Properties
Molecular Formula: Osimertinib β C28H33N7O2; Trimethoprim β C14H18N4O3.
Molecular Weight: Osimertinib β 499.6050 g/mol; Trimethoprim β 290.3180 g/mol.
Type: Osimertinib β Small molecule; Trimethoprim β Small molecule.